Human Genome Epidemiology Literature Finder
|
Records 1 - 3 (of 3 Records) |
| Query Trace: Anemia and SLC28A3[original query] |
|---|
| Role of nucleoside transporters SLC28A2/3 and SLC29A1/2 genetics in ribavirin therapy: protection against anemia in patients with chronic hepatitis C. Pharmacogenetics and genomics 2011 May 21 (5): 289-96. Doehring Alexandra, Hofmann Wolf Peter, Schlecker Christina, Zeuzem Stefan, Sarrazin Christoph, Berg Thomas, Müller Tobias, Herrmann Eva, Geisslinger Gerd, Lötsch Jö |
| Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection. Journal of hepatology 2013 Apr 58 (4): 669-75. Rau Monika, Stickel Felix, Russmann Stefan, Manser Christine N, Becker Philip P, Weisskopf Michael, Schmitt Johannes, Dill Michael T, Dufour Jean-François, Moradpour Darius, Semela David, Müllhaupt Beat, Geier Andreas, |
| Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV-hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapy. AIDS (London, England) 2016 May . Kheloufi Farid, Bellissant Eric, Cotte Laurent, Poizot-Martin Isabelle, Quaranta Sylvie, Garraffo Rodolphe, Barrail-Tran Aurélie, Renault Alain, Fournier Isabelle, Lacarelle Bruno, Bourlière Marc, Molina Jean-Michel, Solas Caroline, |
- Page last reviewed:Feb 1, 2024
- Content source: